RA CAPITAL MANAGEMENT, L.P. Diversified Active

Location: Boston, MA

CIK: 0001346824 · Show all filings

Period: Q3 2018 (← Previous) (Next →)

Filing Date: Nov 14, 2018

Total Value: $1.871B (100.0% shares, 0.0% debt)

Holdings (26)

WVE WAVE LIFE SCIENCES LTD 20.1%
Value $376M Shares 7,512,049 Share Price $50.00 * Est. Cost/Share $16.44 Unrealized @ Report Date +174.5%
ASND ASCENDIS PHARMA A S 16.1%
Value $300M Shares 4,240,536 Share Price $70.86 Est. Cost/Share $17.96 Unrealized @ Report Date —
— SOLID BIOSCIENCES INC 6.8%
Value $127M Shares 2,689,444 Share Price $47.18 Est. Cost/Share $7.50 Unrealized @ Report Date —
— ENDOCYTE INC 5.9%
Value $110M Shares 6,196,143 Share Price $17.76 Est. Cost/Share $8.59 Unrealized @ Report Date —
— ZOGENIX INC 5.0%
Value $93.19M Shares 1,878,768 Share Price $49.60 Est. Cost/Share $29.66 Unrealized @ Report Date —
— MYOVANT SCIENCES LTD 4.9%
Value $91.65M Shares 3,451,859 Share Price $26.55 Est. Cost/Share $14.71 Unrealized @ Report Date —
BCRX BIOCRYST PHARMACEUTICALS 3.8%
Value $70.46M Shares 9,234,692 Share Price $7.63 * Est. Cost/Share $7.23 Unrealized @ Report Date -7.1%
— RA PHARMACEUTICALS INC 3.7%
Value $69.68M Shares 3,851,808 Share Price $18.09 Est. Cost/Share $8.78 Unrealized @ Report Date —
IFRX INFLARX NV 3.6%
Value $67.54M Shares 1,967,848 Share Price $34.32 * Est. Cost/Share $20.89 Unrealized @ Report Date +54.4%
— IMMUNOMEDICS INC 3.5%
Value $64.98M Shares 3,119,778 Share Price $20.83 Est. Cost/Share $23.67 Unrealized @ Report Date —
— DICERNA PHARMACEUTICALS INC 3.2%
Value $60.02M Shares 3,933,489 Share Price $15.26 Est. Cost/Share $18.43 Unrealized @ Report Date —
RYTM RHYTHM PHARMACEUTICALS INC 3.0%
Value $56.89M Shares 1,950,332 Share Price $29.17 * Est. Cost/Share $28.23 Unrealized @ Report Date +11.9%
ARVN ARVINAS INC 2.8%
Value $52.95M Shares 3,138,412 Share Price $16.87 * Est. Cost/Share $16.46 Unrealized @ Report Date 0.0%
— SAGE THERAPEUTICS INC 2.7%
Value $49.57M Shares 350,933 Share Price $141.25 Est. Cost/Share $164.71 Unrealized @ Report Date —
CRNX CRINETICS PHARMACEUTICALS INC 2.6%
Value $48.73M Shares 1,701,017 Share Price $28.65 * Est. Cost/Share $29.69 Unrealized @ Report Date 0.0%
TGTX TG THERAPEUTICS INC 2.5%
Value $45.91M Shares 8,198,337 Share Price $5.60 * Est. Cost/Share $12.35 Unrealized @ Report Date -7.5%
— MOMENTA PHARMACEUTICALS INC 2.2%
Value $40.98M Shares 1,558,357 Share Price $26.30 Est. Cost/Share $20.45 Unrealized @ Report Date —
KALV KALVISTA PHARMACEUTICALS INC 1.7%
Value $31.86M Shares 1,441,070 Share Price $22.11 * Est. Cost/Share $9.16 Unrealized @ Report Date +47.5%
— EIDOS THERAPEUTICS INC 1.2%
Value $21.58M Shares 2,162,671 Share Price $9.98 Est. Cost/Share $20.34 Unrealized @ Report Date —
— KALA PHARMACEUTICALS INC 1.1%
Value $20.86M Shares 2,113,236 Share Price $9.87 Est. Cost/Share $22.84 Unrealized @ Report Date —
— PROGENICS PHARMACEUTICALS INC 1.0%
Value $19M Shares 3,030,303 Share Price $6.27 Est. Cost/Share $6.27 Unrealized @ Report Date —
— SCPHARMACEUTICALS INC 0.9%
Value $16.77M Shares 2,857,143 Share Price $5.87 Est. Cost/Share $12.09 Unrealized @ Report Date —
APLS APELLIS PHARMACEUTICALS INC 0.9%
Value $16M Shares 900,000 Share Price $17.78 * Est. Cost/Share $14.72 Unrealized @ Report Date +25.6%
IOVA IOVANCE BIOTHERAPEUTICS INC 0.7%
Value $12.61M Shares 1,121,153 Share Price $11.25 * Est. Cost/Share $14.93 Unrealized @ Report Date -4.9%
— GLYCOMIMETICS INC 0.2%
Value $3.651M Shares 253,547 Share Price $14.40 Est. Cost/Share $16.23 Unrealized @ Report Date —
— PROTEON THERAPEUTICS INC 0.1%
Value $2.608M Shares 1,337,462 Share Price $1.95 Est. Cost/Share $1.53 Unrealized @ Report Date —